Buy Ocrevus Ocrelizumab 300mg Injection Online at Best Price – GlobMedIndia in India.

Ocrevus Ocrelizumab 300mg Injection

Introduction

Ocrevus Ocrelizumab 300mg Injection is a targeted biologic therapy used primarily for the treatment of multiple sclerosis (MS). It contains Ocrelizumab, a monoclonal antibody designed to selectively target and destroy CD20-positive B cells, which play a key role in damaging the nervous system in MS patients.

Unlike traditional therapies, Ocrevus works at the immune system level, helping to slow disease progression, reduce relapses, and improve long-term neurological outcomes. It is widely prescribed for both Relapsing-Remitting Multiple Sclerosis (RRMS) and Primary Progressive Multiple Sclerosis (PPMS).

Contact Details for Ordering

Contact Details:-

💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com

Composition and Content

Active Ingredient: Ocrelizumab
Strength: 300 mg / 10 mL vial
Form: Concentrated solution for intravenous (IV) infusion
Class: Anti-CD20 monoclonal antibody

How to Use

Administered only under medical supervision in a hospital or clinical setting.
Given as an intravenous infusion (IV drip).
Pre-medications (like corticosteroids and antihistamines) are usually given to reduce infusion-related reactions.

Dosage and Administration

Initial Dose:
- 300 mg IV infusion followed by another 300 mg infusion after 2 weeks
Maintenance Dose:
- 600 mg IV infusion every 6 months

⚠️ Dosage may vary based on patient condition and doctor’s recommendation.

Uses and Indications

Ocrevus is used for treating:

Relapsing-Remitting Multiple Sclerosis (RRMS)
Primary Progressive Multiple Sclerosis (PPMS)
Helps in:
- Reducing frequency of relapses
- Slowing disability progression
- Decreasing brain lesions

Treatment Benefits

Targeted therapy with high efficacy
Suitable for early and advanced MS cases
Long dosing interval (every 6 months) improves compliance
Proven to delay disease progression
Reduces inflammation and nerve damage

Advantages

First approved therapy for PPMS
Fewer relapses compared to conventional treatments
Long-lasting effect with minimal dosing frequency
Improves quality of life in MS patients

Storage Conditions

Store at 2°C to 8°C (refrigerated)
Do not freeze or shake
Keep in original packaging to protect from light
Use immediately after dilution as per medical guidelines

Alternative Indian Brands for Ocrelizumab

While Ocrelizumab is a specialized biologic with limited generic availability in India, some biosimilar or alternative immunotherapy options (based on doctor’s advice) include:

Rituximab-based therapies (off-label for MS)
- Brands like:
  - Reditux (Dr. Reddy’s Laboratories)
  - Rituxan (Roche)
Other MS disease-modifying therapies:
- Fingolimod
- Natalizumab
- Teriflunomide

⚠️ Always consult a neurologist before switching or choosing alternatives.